Target detail
ABAT
4-aminobutyrate aminotransferase
Data: Live structured evidence (Supabase)
Foundation row from public.targets — full Open Targets / ChEMBL preload remains a future operator job (Phase 8H+).
Display name: 4-aminobutyrate aminotransferase
Aliases: ABAT, 4-aminobutyrate aminotransferase
Type / organism: protein_coding · Homo sapiens
Source: opentargets · ENSG00000183044
Index freshness: last_synced_at 2026-05-15T18:43:46.586+00:00 · updated 2026-05-15T18:43:47.062143+00:00
Limitations & build flags
- Read-only structured navigator
- No clinical outcome benefit inferred
- Trial presence does not imply success
- Drug identity may require normalization
- Terminated/withdrawn trials must remain visible
This symbol is listed in public.targets (operator seed or future preload). Connector-backed sections below may still show empty states until ChEMBL / Open Targets / ClinicalTrials.gov mirror rows exist for this marker.
Connectors represented in loaded rows for ABAT. Empty groups mean no matching rows — not a claim about biology or clinical use.
- Open TargetsLive when indexed
Disease–target evidence rows when operators run enrich:opentargets (GraphQL from trusted scripts only).
- ChEMBLLive when indexed
Drug–target and related enrichment rows when operators run enrich:chembl (server/CLI only).
Rows from disease_target_evidence for this symbol.
glioblastoma
literature · opentargets
Drug records tied via drug_targets — mechanistic linkage only.
VIGABATRIN
chembl89598
CHEMBL353363
chembl353363
CHEMBL311337
chembl311337
CHEMBL138407
chembl138407
CHEMBL141917
chembl141917
GAMMA-AMINOBUTYRIC ACID
chembl96
VALPROIC ACID
chembl109
CHEMBL336887
chembl336887
CHEMBL137992
chembl137992
4-HYDROXYBENZALDEHYDE
chembl14193
CHEMBL202519
chembl202519
PAROXYPROPIONE
chembl312311
PARAHYDROXYBENZYL ALCOHOL
chembl202132
CHEMBL378577
chembl378577
4-HYDROXYACETOPHENONE
chembl201083
CHEMBL378361
chembl378361
AMINOBENZOIC ACID
chembl542
GASTRODIN
chembl274739
VANILLIN
chembl13883
PARABEN
chembl441343
HELICIDE
chembl201358
CHEMBL202440
chembl202440
CHEMBL391954
chembl391954
CHEMBL541141
chembl541141
ANISALDEHYDE
chembl161598
CHEMBL202611
chembl202611
CHEMBL248094
chembl248094
ANTHRANILIC ACID
chembl14173
CHEMBL535865
chembl535865
CHEMBL535644
chembl535644
CHEMBL535643
chembl535643
CHEMBL449219
chembl449219
CHEMBL453851
chembl453851
CHEMBL454869
chembl454869
CHEMBL535415
chembl535415
3-AMINOBENZOIC ACID
chembl307782
CHEMBL510653
chembl510653
CHEMBL451637
chembl451637
CHEMBL443162
chembl443162
CHEMBL509998
chembl509998
CHEMBL455241
chembl455241
CHEMBL452997
chembl452997
CHEMBL446229
chembl446229
CHEMBL503250
chembl503250
CHEMBL444753
chembl444753
CHEMBL500080
chembl500080
CHEMBL487467
chembl487467
CHEMBL486451
chembl486451
CHEMBL488502
chembl488502
CHEMBL487466
chembl487466
CHEMBL474225
chembl474225
CHEMBL509352
chembl509352
CHEMBL292594
chembl292594
CHEMBL449169
chembl449169
CHEMBL486450
chembl486450
CHEMBL443093
chembl443093
CHEMBL510648
chembl510648
CHEMBL486653
chembl486653
CHEMBL486655
chembl486655
CHEMBL486654
chembl486654
CHEMBL503579
chembl503579
CHEMBL446823
chembl446823
CHEMBL461595
chembl461595
CHEMBL506758
chembl506758
CHEMBL112496
chembl112496
CHEMBL443366
chembl443366
CHEMBL451303
chembl451303
CHEMBL321931
chembl321931
CHEMBL2203661
chembl2203661
CHEMBL2235131
chembl2235131
CHEMBL2235129
chembl2235129
CHEMBL2206397
chembl2206397
CHEMBL2235130
chembl2235130
CHEMBL2235128
chembl2235128
CHEMBL2235126
chembl2235126
CHEMBL2235124
chembl2235124
CHEMBL2235122
chembl2235122
CHEMBL2235120
chembl2235120
CHEMBL2235135
chembl2235135
CHEMBL2235127
chembl2235127
CHEMBL2235125
chembl2235125
CHEMBL2235123
chembl2235123
CHEMBL2235121
chembl2235121
CHEMBL2235136
chembl2235136
CHEMBL2235134
chembl2235134
CHEMBL2235133
chembl2235133
BAICALEIN
chembl8260
CHEMBL163117
chembl163117
BETA-PHENYLETHYLIDENE HYDRAZINE
chembl2235132
CHEMBL3774784
chembl3774784
CHEMBL5404015
chembl5404015
CHEMBL4746439
chembl4746439
CHEMBL5408239
chembl5408239
IPP/CNRS-A017
chembl3589752
CHEMBL4750359
chembl4750359
CHEMBL4740703
chembl4740703
BAY-3827
chembl4580220
KISS1-543
chembl4588626
BI-605906
chembl4522930
CHEMBL6004483
chembl6004483
CHEMBL6034685
chembl6034685
CHEMBL5744522
chembl5744522
BI 2545
chembl4165749
TP-020n
chembl4585920
CHEMBL5800591
chembl5800591
CHEMBL5870771
chembl5870771
CHEMBL5759791
chembl5759791
CHEMBL5797769
chembl5797769
CHEMBL1361446
chembl1361446
CHEMBL6003357
chembl6003357
disease_drug_evidence rows on linked drugs whose evidence_type suggests approved-elsewhere discussion context.
No matching rows
Import repoDB-compatible disease–drug evidence or add structured rows to surface discussion candidates here.
Mirror rows whose text fields mention this symbol — registry context only.
No matching live evidence found
Populate clinical_trials via the registry enrichment flow; this panel matches the symbol token in titles, conditions, or interventions.
Repurposing signal rows for drugs linked to this target via drug_targets.
No research signals for linked drugs
Run the deterministic signal builder after drug_targets and source rows are present.
Structured rows with negative evidence_direction on disease–drug or signal tables.
No negative-direction rows
When structured evidence includes explicit negative direction fields, they surface here for oncology review.
No ClinicalTrials.gov mirror rows mention this symbol in titles, conditions, or interventions (within the loaded window).
- chembl: 110
- opentargets: 1
Structured evidence rows link this marker to cohort contexts when ingested — interpret as research context only.
Disease contexts
0
Linked drugs
0
Linked in dataset
0
Research signals
0
Doctor-discussion candidate and related tags are descriptive only.
Signals list: Live structured evidence (Supabase)
No matching live evidence found
When repurposing_signal rows reference this marker via linked drugs, summaries appear here.